These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 11181704)

  • 1. BCL-2 cooperates with promyelocytic leukemia retinoic acid receptor alpha chimeric protein (PMLRARalpha) to block neutrophil differentiation and initiate acute leukemia.
    Kogan SC; Brown DE; Shultz DB; Truong BT; Lallemand-Breitenbach V; Guillemin MC; Lagasse E; Weissman IL; Bishop JM
    J Exp Med; 2001 Feb; 193(4):531-43. PubMed ID: 11181704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukemia initiated by PMLRARalpha: the PML domain plays a critical role while retinoic acid-mediated transactivation is dispensable.
    Kogan SC; Hong SH; Shultz DB; Privalsky ML; Bishop JM
    Blood; 2000 Mar; 95(5):1541-50. PubMed ID: 10688806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A PMLRARalpha transgene initiates murine acute promyelocytic leukemia.
    Brown D; Kogan S; Lagasse E; Weissman I; Alcalay M; Pelicci PG; Atwater S; Bishop JM
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2551-6. PubMed ID: 9122233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of promyelocytic leukemia (PML) protein in tumor suppression.
    Rego EM; Wang ZG; Peruzzi D; He LZ; Cordon-Cardo C; Pandolfi PP
    J Exp Med; 2001 Feb; 193(4):521-29. PubMed ID: 11181703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia.
    Guibal FC; Alberich-Jorda M; Hirai H; Ebralidze A; Levantini E; Di Ruscio A; Zhang P; Santana-Lemos BA; Neuberg D; Wagers AJ; Rego EM; Tenen DG
    Blood; 2009 Dec; 114(27):5415-25. PubMed ID: 19797526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute promyelocytic leukemia: a view from a mouse.
    Kogan SC
    Blood Cells Mol Dis; 2000 Dec; 26(6):620-5. PubMed ID: 11358354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PML-RAR induces promyelocytic leukemias with high efficiency following retroviral gene transfer into purified murine hematopoietic progenitors.
    Minucci S; Monestiroli S; Giavara S; Ronzoni S; Marchesi F; Insinga A; Diverio D; Gasparini P; Capillo M; Colombo E; Matteucci C; Contegno F; Lo-Coco F; Scanziani E; Gobbi A; Pelicci PG
    Blood; 2002 Oct; 100(8):2989-95. PubMed ID: 12351412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice parallel human acute promyelocytic leukemia.
    Le Beau MM; Bitts S; Davis EM; Kogan SC
    Blood; 2002 Apr; 99(8):2985-91. PubMed ID: 11929790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two critical hits for promyelocytic leukemia.
    He LZ; Bhaumik M; Tribioli C; Rego EM; Ivins S; Zelent A; Pandolfi PP
    Mol Cell; 2000 Nov; 6(5):1131-41. PubMed ID: 11106752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PMLRARα binds to Fas and suppresses Fas-mediated apoptosis through recruiting c-FLIP in vivo.
    Tao RH; Berkova Z; Wise JF; Rezaeian AH; Daniluk U; Ao X; Hawke DH; Karp JE; Lin HK; Molldrem JJ; Samaniego F
    Blood; 2011 Sep; 118(11):3107-18. PubMed ID: 21803845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoic acid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice.
    Kinjo K; Kizaki M; Muto A; Fukuchi Y; Umezawa A; Yamato K; Nishihara T; Hata J; Ito M; Ueyama Y; Ikeda Y
    Leukemia; 2000 Mar; 14(3):431-8. PubMed ID: 10720138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice.
    He LZ; Tribioli C; Rivi R; Peruzzi D; Pelicci PG; Soares V; Cattoretti G; Pandolfi PP
    Proc Natl Acad Sci U S A; 1997 May; 94(10):5302-7. PubMed ID: 9144232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haploinsufficiency for tumor suppression: the hazards of being single and living a long time.
    Largaespada DA
    J Exp Med; 2001 Feb; 193(4):F15-8. PubMed ID: 11181707
    [No Abstract]   [Full Text] [Related]  

  • 14. Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice identify cooperating events and genetic pathways to acute promyelocytic leukemia.
    Le Beau MM; Davis EM; Patel B; Phan VT; Sohal J; Kogan SC
    Blood; 2003 Aug; 102(3):1072-4. PubMed ID: 12689927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired, nonrandom chromosomal abnormalities associated with the development of acute promyelocytic leukemia in transgenic mice.
    Zimonjic DB; Pollock JL; Westervelt P; Popescu NC; Ley TJ
    Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13306-11. PubMed ID: 11087871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon augments PML and PML/RAR alpha expression in normal myeloid and acute promyelocytic cells and cooperates with all-trans retinoic acid to induce maturation of a retinoid-resistant promyelocytic cell line.
    Nason-Burchenal K; Gandini D; Botto M; Allopenna J; Seale JR; Cross NC; Goldman JM; Dmitrovsky E; Pandolfi PP
    Blood; 1996 Nov; 88(10):3926-36. PubMed ID: 8916959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of wild-type retinoic acid receptor alpha (RARalpha) recapitulates retinoic acid-sensitive transformation of primary myeloid progenitors by acute promyelocytic leukemia RARalpha-fusion genes.
    Du C; Redner RL; Cooke MP; Lavau C
    Blood; 1999 Jul; 94(2):793-802. PubMed ID: 10397747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
    Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
    Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR alpha under control of cathepsin G regulatory sequences.
    Grisolano JL; Wesselschmidt RL; Pelicci PG; Ley TJ
    Blood; 1997 Jan; 89(2):376-87. PubMed ID: 9002938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A bcr-3 isoform of RARalpha-PML potentiates the development of PML-RARalpha-driven acute promyelocytic leukemia.
    Pollock JL; Westervelt P; Kurichety AK; Pelicci PG; Grisolano JL; Ley TJ
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15103-8. PubMed ID: 10611345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.